Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.
about
Non-surgical interventions for the management of chronic pelvic painEffectiveness of gefitinib in combination with methotrexate in the treatment of ectopic pregnancy.Prioritization of Susceptibility Genes for Ectopic Pregnancy by Gene Network Analysis.Opportunities and challenges in using studies without a control group in comparative effectiveness reviews.
P2860
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II single arm open label ...... cies (GEM II): study protocol.
@en
Phase II single arm open label ...... reat tubal ectopic pregnancies
@nl
type
label
Phase II single arm open label ...... cies (GEM II): study protocol.
@en
Phase II single arm open label ...... reat tubal ectopic pregnancies
@nl
prefLabel
Phase II single arm open label ...... cies (GEM II): study protocol.
@en
Phase II single arm open label ...... reat tubal ectopic pregnancies
@nl
P2093
P2860
P50
P1433
P1476
Phase II single arm open label ...... cies (GEM II): study protocol.
@en
P2093
Hilary O D Critchley
Jane E Norman
Jill Mollison
Michael Rassmusen
Monika M Skubisz
W Colin Duncan
P2860
P304
P356
10.1136/BMJOPEN-2013-002902
P577
2013-07-19T00:00:00Z